Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Annexin V-Directed Enzyme Prodrug Therapy Plus Docetaxel for the Targeted Treatment of Pancreatic Cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Annexin V-Directed Enzyme Prodrug Therapy Plus Docetaxel for the Targeted Treatment of Pancreatic Cancer.
Guillen KP, Restuccia A, Kurkjian C, Harrison RG. Annexin V-Directed Enzyme Prodrug Therapy Plus Docetaxel for the Targeted Treatment of Pancreatic Cancer. Pancreas. 2015 Aug; 44(6):945-52.
View in:
PubMed
subject areas
Adenine
Adenine
Adenocarcinoma
Adenocarcinoma
Annexin A5
Annexin A5
Antineoplastic Combined Chemotherapy Protocols
Antineoplastic Combined Chemotherapy Protocols
Carbon-Sulfur Lyases
Carbon-Sulfur Lyases
Cell Death
Cell Death
Cell Line, Tumor
Cell Line, Tumor
Cytosine Deaminase
Cytosine Deaminase
Dose-Response Relationship, Drug
Dose-Response Relationship, Drug
Enzymes
Enzymes
Flucytosine
Flucytosine
Fluorouracil
Fluorouracil
Humans
Humans
Methanol
Methanol
Molecular Targeted Therapy
Molecular Targeted Therapy
Organoselenium Compounds
Organoselenium Compounds
Pancreatic Neoplasms
Pancreatic Neoplasms
Prodrugs
Prodrugs
Purine-Nucleoside Phosphorylase
Purine-Nucleoside Phosphorylase
Recombinant Fusion Proteins
Recombinant Fusion Proteins
Selenomethionine
Selenomethionine
Taxoids
Taxoids
Tubulin Modulators
Tubulin Modulators
Vidarabine
Vidarabine
authors with profiles
Roger G Harrison